Consun Pharmaceutical Group Limited Stock Deutsche Boerse AG
Equities
C1P
KYG2524A1031
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.54 EUR | -0.92% | -28.95% | +1.89% |
Sales 2023 | 2.59B 357M 334M | Sales 2024 * | 2.94B 406M 379M | Capitalization | 4.16B 575M 538M |
---|---|---|---|---|---|
Net income 2023 | 785M 108M 101M | Net income 2024 * | 928M 128M 120M | EV / Sales 2023 | 1.33 x |
Net cash position 2023 * | 2.19B 303M 283M | Net cash position 2024 * | 2.87B 396M 371M | EV / Sales 2024 * | 0.44 x |
P/E ratio 2023 |
4.42
x | P/E ratio 2024 * |
4.6
x | Employees | 3,127 |
Yield 2023 * |
5.72% | Yield 2024 * |
6.67% | Free-Float | 42.31% |
1 day | -0.92% | ||
1 week | -28.95% | ||
Current month | -18.18% | ||
1 month | -25.00% | ||
3 months | -6.90% | ||
Current year | +1.89% |
Managers | Title | Age | Since |
---|---|---|---|
Meng An
CEO | Chief Executive Officer | 52 | 21-03-23 |
Pei Cheng Fang
DFI | Director of Finance/CFO | 45 | 10-07-31 |
Han Xing Xu
BRD | Director/Board Member | 30 | 20-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Quan Zhu
BRD | Director/Board Member | 84 | 12-12-23 |
Zhong Shi Feng
BRD | Director/Board Member | 65 | 13-12-01 |
Yu Jun Chen
BRD | Director/Board Member | 44 | 13-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.54 | -0.92% | 0 |
24-04-25 | 0.545 | +0.93% | 0 |
24-04-24 | 0.54 | +0.93% | 0 |
24-04-23 | 0.535 | 0.00% | 0 |
24-04-22 | 0.535 | -29.61% | 0 |
Delayed Quote Deutsche Boerse AG, April 26, 2024 at 04:30 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.62% | 43.34B | |
+20.44% | 21.96B | |
+10.86% | 14.09B | |
+13.07% | 13.64B | |
+37.46% | 11.43B | |
-8.59% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+8.46% | 5.22B |
- Stock Market
- Equities
- 1681 Stock
- C1P Stock